May 21, 2026 Arsenal Medical Receives FDA IDE Approval for the RADIANT Pivotal Trial of NeoCast™ RADIANT is a prospective, randomized, multicenter study for the treatment of symptomatic subacute and chronic subdural hematoma (cSDH) adjunctively with surgery.
